MEDICAMENT RELEASE FROM SUPPOSITORY BASES .3. IBUPROFEN - PHYSICOCHEMICAL CHARACTERISTICS AND BIOAVAILABILITY IN RABBITS

被引：4

作者：

ALI, A ^{[1
]}

KAZMI, S ^{[1
]}

DEUTSCH, T ^{[1
]}

PLAKOGIANNIS, FM ^{[1
]}

机构：

[1] LONG ISL UNIV,ARNOLD & MARIE SCHWARTZ COLL PHARM & HLTH SCI,DIV PHARMACEUT,BROOKLYN,NY 11201

来源：

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY | 1982年 / 8卷 / 03期

关键词：

D O I：

10.3109/03639048209022109

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：411 / 428

页数：18

共 17 条

[1]

ADAMS SS, 1969, ARCH INT PHARMACOD T, V178, P115

[2]

Adams SS, 1970, RHEUMATOL PHYS M S10, V10, P9

[3]

ADAMS SS, 1967, J PHARM SCI, V56, P1687

[4] IBUPROFEN IN TREATMENT OF RHEUMATOID ARTHRITIS AND OSTEO-ARTHRITIS [J].

BOARDMAN, PL ;

NUKI, G ;

HART, FD .

ANNALS OF THE RHEUMATIC DISEASES, 1967, 26 (06) :560-&

[5]

BROOKS CD, 1973, CURR THER RES CLIN E, V15, P180

[6] CLINICAL EXPERIENCE WITH IBUPROFEN IN TREATMENT OF RHEUMATOID ARTHRITIS [J].

CHALMERS, TM .

ANNALS OF THE RHEUMATIC DISEASES, 1969, 28 (05) :513-&

[7] MEDICAMENT RELEASE FROM SUPPOSITORY BASES .2. NAPROXEN PHYSICOCHEMICAL CHARACTERISTICS AND BIOAVAILABILITY IN RABBITS [J].

CHONGSATHIEN, G ;

PLAKOGIANNIS, FM .

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1980, 6 (03) :255-278

[8]

CORRIGAN OI, 1968, PHARM ACTA HELV, V51, P268

[9]

CORSON SL, 1978, J REPROD MED, V20, P246

[10]

GOLDBERG AA, 1971, PRACTITIONER, V207, P343

← 1 2 →